Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech shares slipped 0.2% to $19.72 in premarket trading Tuesday after a 9% jump the previous session, following news of Gilead’s $7.8 billion deal to buy Arcellx. The acquisition put focus on rival CAR-T therapies, with Arcellx’s anito-cel under FDA review and analysts citing possible safety advantages over Legend’s Carvykti, which generated $1.9 billion in 2025 sales.
24 February 2026
Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics shares fell 0.5% to $34.30 in premarket trading Tuesday after an 11.1% surge Monday, as investors reacted to new obesity drug trial data from Novo Nordisk. Novo’s CagriSema showed less weight loss than Eli Lilly’s rival drug, shaking the sector. Viking plans to advance its oral obesity drug VK2735 into late-stage trials in Q3. Investors await updates at upcoming healthcare conferences in March and April.
Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America shares were little changed in premarket trading Tuesday after closing down 3.75% amid a broad selloff in bank stocks. The KBW Regional Banking Index dropped 4.26% Monday as Treasury yields swung and investors weighed tariff headlines. JPMorgan, Wells Fargo, and Morgan Stanley each fell about 4%. U.S. stock futures edged higher early Tuesday ahead of key earnings and policy events.
Blue Owl stock price drops premarket after Deutsche Bank downgrade as private-credit jitters linger

Blue Owl stock price drops premarket after Deutsche Bank downgrade as private-credit jitters linger

Blue Owl Capital shares dropped 4.2% in premarket trading Tuesday after Deutsche Bank downgraded the stock to Hold and cut its price target to $10. The move follows rising investor concern over private-credit fund liquidity and exposure to software loans. Blue Owl has lost over 16% in five days amid headlines on fund withdrawals and a disputed financing issue tied to CoreWeave. Investors are watching for the March 2 dividend payment.
24 February 2026
Palantir stock price slides with software selloff; tariffs and Nvidia earnings set the next test

Palantir stock price slides with software selloff; tariffs and Nvidia earnings set the next test

Palantir shares fell 3.4% to $130.60 on Monday as investors sold off high-risk software stocks amid tariff uncertainty and renewed debate over AI disruption. U.S. stock indexes also declined, with software among the hardest hit. Traders are watching for Nvidia’s earnings report Wednesday, seen as the next major driver for AI-linked stocks. Futures edged higher early Tuesday, but markets remain volatile as tariff policy shifts.
American Airlines stock slips before open as Northeast blizzard snarls flights and shelf filing hits tape

American Airlines stock slips before open as Northeast blizzard snarls flights and shelf filing hits tape

American Airlines shares fell 4.8% to $12.93 in premarket trading after a Northeast blizzard forced widespread flight cancellations. The company also filed a shelf registration late Monday, allowing for possible future sales of stock or debt. Operations resumed at Washington Reagan National and Philadelphia, with New York and Boston expected later Tuesday. Delta and United stocks also declined.
24 February 2026
Novo Nordisk stock slips again as CagriSema miss drives forecast cuts and puts next catalysts in focus

Novo Nordisk stock slips again as CagriSema miss drives forecast cuts and puts next catalysts in focus

Novo Nordisk shares fell 2.5% to 245.1 Danish crowns Tuesday after its CagriSema obesity drug failed to match Eli Lilly’s tirzepatide in a Phase 3 trial. Barclays cut its peak sales forecast for CagriSema to $2 billion from $12 billion. Novo also reported mid-stage China trial results for its “triple G” obesity drug UBT251, showing up to 19.7% weight loss after 24 weeks.
Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia shares traded at $191.55, up 0.9%, ahead of quarterly results due Wednesday after the bell. Options markets signal a possible 6% swing in either direction, reflecting investor focus on AI demand, supply constraints, and China sales. Wall Street expects revenue to jump over 68% to $66.16 billion. The company will release results at 4:20 p.m. ET, with a conference call at 5 p.m.
Gossamer Bio stock tumbles again premarket as Phase 3 PAH miss rewrites the story

Gossamer Bio stock tumbles again premarket as Phase 3 PAH miss rewrites the story

Gossamer Bio shares traded near $0.42 in early premarket Tuesday after plunging about 80% when its main drug failed to meet the primary goal in a Phase 3 trial. The company said the study’s key endpoint improved by 13.3 meters but did not reach statistical significance. Analysts downgraded the stock and flagged risks around funding and regulatory timelines. Gossamer plans to meet the FDA and paused another study.
Shopify stock price slides 7% as tariff fog, AI jitters squeeze software names

Shopify stock price slides 7% as tariff fog, AI jitters squeeze software names

Shopify shares fell 7.1% to $117.28 on Monday, their steepest drop in weeks, as investors sold off software stocks amid U.S. tariff uncertainty and AI disruption fears. The S&P 500 software group slid 4.3%. U.S. Customs set a 10% tariff rate starting Tuesday, with a possible increase to 15% under discussion. No new Shopify announcements were made Monday.
American Express stock tumbles 7% as “AI scare trade” hits payments; what to watch before the open

American Express stock tumbles 7% as “AI scare trade” hits payments; what to watch before the open

American Express shares fell 7.2% to $321.24, among the steepest drops on the Dow, after a weekend research note warned AI could disrupt card fees and spending. The decline was not linked to company earnings but sparked broader selling in payments stocks, with Visa and Capital One also down. Investors are watching upcoming U.S. data and Federal Reserve signals for further direction.
Go toTop